Jagsonpal Pharmaceuticals Ltd
NSE:JAGSNPHARM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jagsonpal Pharmaceuticals Ltd
NSE:JAGSNPHARM
|
IN |
|
C
|
China Wantian Holdings Ltd
HKEX:1854
|
HK |
|
Hubei Xiangyuan New Material Technology Inc
SZSE:300980
|
CN |
|
Bicicletas Monark SA
BOVESPA:BMKS3
|
BR |
|
B
|
Brigham Minerals Inc
F:2TQ
|
US |
|
Japan Petroleum Exploration Co Ltd
TSE:1662
|
JP |
|
L
|
Lubair Aviation Technology Co Ltd
SZSE:001316
|
CN |
|
IVP Ltd
NSE:IVP
|
IN |
|
Topdanmark A/S
CSE:TOP
|
DK |
|
F
|
Foods and Inns Ltd
NSE:FOODSIN
|
IN |
|
Skako A/S
CSE:SKAKO
|
DK |
|
Blacksky Technology Inc
NYSE:BKSY
|
US |
|
Z
|
Zeal Aqua Ltd
BSE:539963
|
IN |
|
Nikon Corp
TSE:7731
|
JP |
|
BPM Minerals Ltd
ASX:BPM
|
AU |
Bankruptcy Probability
Jagsonpal Pharmaceuticals Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Jagsonpal Pharmaceuticals Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
|
Jagsonpal Pharmaceuticals Ltd
NSE:JAGSNPHARM
|
12.7B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
879.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Jagsonpal Pharmaceuticals Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Jagsonpal Pharmaceuticals Ltd has total debt of 71.9m INR. This includes both short-term (0 INR) and long-term (71.9m INR) debt.
You can find a full breakdown on its Balance Sheet.
